| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.008 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.35 | 0.008 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.39 | 0.009 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |